Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
Biochemical and Biophysical Research Communications|February 26, 2026
SDC4 is a novel target of the KLF5 transcription factorYuhki Yokoyama, Hiroyuki Yamamoto, Akane Uomoto, et al.
Oncogene|August 23, 2019
MUC1-C represses the RASSF1A tumor suppressor in human carcinoma cellsHasan Rajabi, Tsuyoshi Hata, Wei Li, et al.
Oncogene|October 3, 2019
Correction: MUC1-C represses the RASSF1A tumor suppressor in human carcinoma cellsHasan Rajabi, Tsuyoshi Hata, Wei Li, et al.
Cancer Science|May 2, 2021
Specific activation of glycolytic enzyme enolase 2 in BRAF V600E-mutated colorectal cancerRyohei Yukimoto, Naohiro Nishida, Tsuyoshi Hata, et al.
Cancer Research|December 22, 2017
MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast CancerTakahiro Maeda, Masayuki Hiraki, Caining Jin, et al.
Surgical Endoscopy|October 13, 2025
Manual repositioning of the small bowel and omentum prevents early postoperative small bowel obstruction after laparoscopic colorectal surgery: a propensity score-matched studyMitsunobu Takeda, Mamoru Uemura, Tsunekazu Mizushima, et al.
Carcinogenesis|May 31, 2022
Low G9a expression is a tumor progression factor of colorectal cancer via IL-8 promotionYoshitoshi Ichikawa, Hidekazu Takahashi, Yoshinao Chinen, et al.
The Journal of Clinical Investigation|August 9, 2011
Desmoglein 3-specific CD4+ T cells induce pemphigus vulgaris and interface dermatitis in miceHayato Takahashi, Michiyoshi Kouno, Keisuke Nagao, et al.
Oncology|July 3, 2019
A Phase I Study of Neoadjuvant Capecitabine, Oxaliplatin, and Irinotecan (XELOXIRI) in Patients with Locally Advanced Rectal CancerToshihiro Kudo, Ichiro Takemasa, Tsuyoshi Hata, et al.
Cancer Research|March 3, 2019
MUC1-C Integrates Chromatin Remodeling and PARP1 Activity in the DNA Damage Response of Triple-Negative Breast Cancer CellsMasaaki Yamamoto, Caining Jin, Tsuyoshi Hata, et al.
Pageof 13